AXL and renal cell carcinoma: Shi et al. reported that tretinoin could be a novel promising drug to overcome RCC resistance by regulating TR4/lncTASR/AXL signaling pathway while also aiding in enhancing sunitinib efficacy in RCC treatment [51].